E Fund Management Co., Ltd. Kura Oncology, Inc. Transaction History

E Fund Management Co., Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$13.42 - $23.53 $197,408 - $346,126	14,710 New	14,710 $313,000
Q3 2023 Nov 13, 2023	BUY	$8.44 - $11.86 $10,980 - $15,429	1,301 Added 12.24%	11,929 $109,000
Q2 2023 Aug 11, 2023	SELL	$9.62 - $13.99 $47,715 - $69,390	-4,960 Reduced 31.82%	10,628 $112,000
Q1 2023 May 11, 2023	SELL	$10.71 - $14.6 $16,975 - $23,141	-1,585 Reduced 9.23%	15,588 $191,000
Q4 2022 Feb 14, 2023	SELL	$11.23 - $16.9 $24,784 - $37,298	-2,207 Reduced 11.39%	17,173 $213,000
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $105,772 - $171,296	8,807 Added 83.3%	19,380 $265,000
Q2 2022 Aug 15, 2022	BUY	$10.71 - $18.33 $62,899 - $107,652	5,873 Added 124.96%	10,573 $194,000
Q1 2021 May 12, 2021	BUY	$24.75 - $39.14 $116,325 - $183,958	4,700 New	4,700 $132,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.